European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial

Phan, Olivier; Henderson, Craig E.; Angelidis, Tatiana; Weil, Patricia; van Toorn, Manja; Rigter, Renske; Soria, Cecilia; Rigter, Henk
January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p110
Academic Journal
Background: MDFT (Multidimensional Family Therapy) is a family based outpatient treatment programme for adolescent problem behaviour. MDFT has been found effective in the USA in adolescent samples differing in severity and treatment delivery settings. On request of five governments (Belgium, France, Germany, the Netherlands, and Switzerland), MDFT has now been tested in the joint INCANT trial (International Cannabis Need of Treatment) for applicability in Western Europe. In each of the five countries, study participants were recruited from the local population of youth seeking or guided to treatment for, among other things, cannabis use disorder. There is little information in the literature if these populations are comparable between sites/countries or not. Therefore, we examined if the study samples enrolled in the five countries differed in baseline characteristics regarding demographics, clinical profile, and treatment delivery setting. Methods: INCANT was a multicentre phase III(b) randomized controlled trial with an open-label, parallel group design. It compared MDFT with treatment as usual (TAU) at and across sites in Berlin, Brussels, Geneva, The Hague and Paris. Participants of INCANT were adolescents of either sex, from 13 through 18 years of age, with a cannabis use disorder (dependence or abuse), and at least one parent willing to take part in the treatment. In total, 450 cases/ families were randomized (concealed) into INCANT. Results: We collected data about adolescent and family demographics (age, gender, family composition, school, work, friends, and leisure time). In addition, we gathered data about problem behaviour (substance use, alcohol and cannabis use disorders, delinquency, psychiatric co-morbidity). There were no major differences on any of these measures between the treatment conditions (MDFT and TAU) for any of the sites. However, there were cross-site differences on many variables. Most of these could be explained by variations in treatment culture, as reflected by referral policy, i.e., participants' referral source. We distinguished 'selfdetermined' referral (common in Brussels and Paris) and referral with some authority-related 'external' coercion (common in Geneva and The Hague). The two referral types were more equally divided in Berlin. Many cross-site baseline differences disappeared when we took referral source into account, but not all. Conclusions: A multisite trial has the advantage of being efficient, but it also carries risks, the most important one being lack of equivalence between local study populations. Our site populations differed in many respects. This is not a problem for analyses and interpretations if the differences somehow can be accounted for. To a major extent, this appeared possible in INCANT. The most important factor underlying the cross-site variations in baseline characteristics was referral source. Correcting for referral source made most differences disappear. Therefore, we will use referral source as a covariate accounting for site differences in future INCANT outcome analyses.


Related Articles

  • A Dangerous Problem. Barclay, James R. // Personnel & Guidance Journal;Sep80, Vol. 59 Issue 1, p5 

    Editorial. Focuses on an article about the medical implication of marijuana abuse for adolescents, published in the September 1980 issue of the 'Personnel and Guidance Journal.' Negative consequences of prolonged use of marijuana; Role of counselors in preventing marijuana abuse in young people.

  • Listening to music with cannabis lyrics encourages use.  // Nursing Standard;6/2/2010, Vol. 24 Issue 39, p17 

    The article presents results from a study that investigated the relationship between cannabis use in urban adolescents and exposure to music with cannabis lyrics.

  • MARIJUANA FACTS: BREAKING DOWN THE MYTHS.  // Scholastic Scope;10/31/2011, Vol. 60 Issue 4, p22 

    The article reports that marijuana use among teenagers in the U.S. is increasing. INSETS: Marijuana Facts: Now You Know;SMOKING MARIJUANA CAN HURT YOUR ABILITY TO….

  • Going Up In Smoke. DiConsiglio, John // Scholastic Choices;Apr2001, Vol. 16 Issue 7, p6 

    Corrects myths about marijuana use among teenagers.

  • Annual survey shows many teens brush off risks of marijuana use. McGill, Natalie // Nation's Health;Feb2013, Vol. 43 Issue 1, p7 

    The article discusses a Monitoring The Future 2012 Teen Drug Use annual survey report that states the number of American teenagers using marijuana has increased since 2007 due to lack of awareness of its effects.

  • MARIJUANA MESS. Fanning, Karen // Scholastic Choices;Apr/May2009, Vol. 24 Issue 6, p9 

    The article relates the experience of a teenage boy who became a marijuana addict and drug dealer to support his addiction.

  • Utility Theory and Adolescent Drug Abusers in Hong Kong. Kee-Lee Chou; Chi'en, James M. N. // Child & Adolescent Social Work Journal;Dec97, Vol. 14 Issue 6, p397 

    Bauman (1980) showed that the perceived costs and benefits of drug abuse predicted adolescents' subsequent marijuana abuse. The purpose of this study was to replicate the Bauman study with Chinese adolescents in Hong Kong, adding further analysis of individual items of perceived costs and...

  • MARIJUANA FACTS: BREAKING DOWN THE MYTHS.  // Scholastic Choices;Oct2011, Vol. 27 Issue 2, p16 

    The article discusses the scientific facts about marijuana use among teenagers which has a negative impact on their body in the U.S.

  • Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. Tan, Carol; Hatam, N.; Treasure, Tom // Journal of the Royal Society of Medicine;Feb2006, Vol. 99 Issue 2, p77 

    The article studies the association between cannabis smoking, bullous lung disease and pneumothorax. It describes the characteristic clinical condition of acute pneumothorax, secondary spontaneous pneumothorax and primary spontaneous pneumothorax. It examines that evidence that cannabis smoking...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics